C8 GBI Good Governance November 2021 Monthly Report – Cirdan Capital

Commentary

The certificate fell by 1% on the month.  The Good Governance premia had been making steady gains before falling, towards the end of the month, as volatility returned to US stocks (the certificate is already back higher in early December).

Looking at the performance of the underlying equities, Tech continues to perform well with Nvidia, HP and Apple the headline outperformers. There was underperformance in Healthcare, as Merck and Waters lost ground after last month’s sharp rise, whilst potential lawsuits against Activision have knocked that stock.

Overall positioning is unchanged in December, with a L/S of 2.25/1.85.

Other posts

December 14: This Week’s Thematic Reads

BY TEMATICA
If you missed out on this week's signals, we've got you covered Read more →

NDR Dynamic Allocation Strategy May 2024 Update

BY BRIAN SANBORN
Dynamic Allocation Strategy, indicators, weightings update Read more →

Thoughts From The Divide: Little Tweaks and Adjustments

BY JON WEBB
“I actually think we’re going to see inflation be choppy, and I expect that we’ll see employment stay robust.” As we noted back in May, “one swallow does not make spring”. But if we are to follow the advice of Keynes/Samuelson, when information changes, we should adjust our conclusions. Blast! The trick is, of course, balancing the two ideas to adjust conclusions when the evidence suggests such an adjustment is appropriate: you might call it Bayesian inference. The above quote from Bostic illustrates the problem, with the Atlanta Fed head implicitly stating that he will be ignoring any hot inflation prints. Read more →
Back to all posts →